Viewing Study NCT01468233


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2025-12-31 @ 11:52 PM
Study NCT ID: NCT01468233
Status: COMPLETED
Last Update Posted: 2021-07-12
First Post: 2011-11-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-11
Start Date Type: None
Primary Completion Date: 2014-04
Primary Completion Date Type: ACTUAL
Completion Date: 2014-04
Completion Date Type: ACTUAL
First Submit Date: 2011-11-07
First Submit QC Date: None
Study First Post Date: 2011-11-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-09-16
Results First Submit QC Date: None
Results First Post Date: 2015-10-28
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2015-05-15
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2021-07-08
Last Update Post Date: 2021-07-12
Last Update Post Date Type: ACTUAL